ABSTRACT 5-Formyluracil (5-foU) is a potentially mutagenic lesion of thymine produced in DNA by ionizing radiation and various chemical oxidants. The elucidation of repair mechanisms for 5-foU will yield important insights into the biological consequences of the lesion. Recently, we reported that 5-foU is recognized and removed from DNA by Escherichia coli enzymes Nth (endonuclease III), Nei (endonuclease VIII) and MutM (formamidopyrimidine DNA glycosylase). Human cells have been shown to have enzymatic activities that release 5-foU from X-rayirradiated DNA, but the molecular identities of these activities are not yet known. In this study, we demonstrate that human hNTH1 (endonuclease III homolog) has a DNA glycosylase/AP lyase activity that recognizes 5-foU in DNA and removes it. hNTH1 cleaved 5-foU-containing duplex oligonucleotides via a b-elimination reaction. It formed Schiff base intermediates with 5-foU-containing oligonucleotides. Furthermore, hNTH1 cleaved duplex oligonucleotides containing all of the 5-foU/N pairs (N = G, A, T or C). The speci®c activities of hNTH1 for cleavage of oligonucleotides containing 5-foU and thymine glycol were 0.011 and 0.045 nM/min/ng protein, respectively. These results indicate that hNTH1 has DNA glycosylase activity with the potential to recognize 5-foU in DNA and remove it in human cells.
INTRODUCTION
Reactive oxygen species (ROS) are generated in living cells during normal cellular metabolism and in response to exogenous inducers such as ionizing radiation and chemical oxidants (1, 2) . ROS cause oxidative base damage to DNA and produce a wide variety of base modi®cations (3, 4) . Certain types of oxidized bases, such as thymine glycol (Tg) and 7,8-dihydro-8-oxoguanine, are cytotoxic and mutagenic (3) . Cells have repair mechanisms that prevent the cell death and mutation caused by oxidative DNA damage (5) . In most organisms, oxidative damage in DNA is primarily repaired by the base excision repair systems (3,6±8) .
Exposure of DNA to ionizing radiation or chemical oxidants leads to the formation of several thymine hydroperoxides (9±11). 5-Hydroperoxymethyluracil spontaneously decomposes to form 5-formyluracil (5-foU) and 5-hydroxymethyluracil (9±11). Recent studies revealed that 5-foU is a potentially mutagenic lesion. Kasai and co-workers (12, 13) found that 5-formyl-2¢-deoxyuridine (5-fodUrd) is mutagenic to bacterial cells when added to the culture medium. Recently we found that the mutation frequency of plasmid pSVK3 containing site-speci®cally incorporated 5-foU is signi®cantly increased compared with that of a normal T/A-containing plasmid (14) . In addition, Klungland et al. (15) showed that the addition of 5-foU or 5-fodUrd to the culture medium promoted mutagenicity at the hprt locus in Chinese hamster ®broblast cells. It is inferred that 5-foU is incorporated into DNA and has base pairing properties different from thymine. These conclusions are supported by the ®ndings that 5-fodUrd is incorporated into the DNA during cell growth and forms mispairs with G, C and T during DNA replication (16, 17) . In fact, it directs misincorporation of mismatched bases opposite the lesion during DNA synthesis in vitro (18, 19) .
It has been reported that Escherichia coil AlkA protein removes 5-foU from DNA in vitro (20) . Furthermore, we recently found that E.coli enzymes Nth (endonuclease III), Nei (endonuclease VIII) and MutM form Schiff base intermediates with oligonucleotides containing 5-foU and cleave the strand at the 5-foU site (21) . These proteins coordinately prevent mutations caused by 5-foU (21, 22) . There are some indications that mammalian cells have similar enzymatic activities that release 5-foU from oxidized DNA (23, 24) . However, the molecular nature of these activities has not been elucidated. The base excision repair system is highly conserved from bacteria to humans (3,6±8,25) . Functional homologs of bacterial DNA glycosylases that act on oxidized bases have been identi®ed in various kinds of eukaryotes. In humans, hOgg1 (8-oxoguanine DNA glycosylase), hMPG (N-alkylpurine glycosylase) and hNTH1 (endonuclease III homolog) show overlapping substrate speci®city with E.coli MutM, AlkA and Nth, respectively (3,6±8,25±27 Hazra et al. (28) reported the presence of two human orthologs of the E.coli nei gene in the human genome database and characterized one of their products. Based on the substrate preference, they named it NEH1 (Nei homolog). The wildtype recombinant NEH1, puri®ed to homogeneity from E.coli, excises formamidopyrimidines from damaged DNA and 8-oxoguanine and oxidized pyrimidines, such as thymine glycol, from oligonucleotides (28) .
hNTH1 has a molecular mass of 36 kDa and is encoded by a gene located in chromosomal region 16p13.3 (29, 30) . The helix±hairpin±helix motif, [4Fe-4S] cluster and lysine residue that is necessary for the formation of the Schiff base intermediate are conserved between the bacterial and human proteins (29, 30) . In addition, both proteins recognize similar substrates, Tg, dihydrouracil and 5-hydroxycytosine (3, 31) . These facts led us to examine whether this protein has a DNA glycosylase activity that recognizes and removes 5-foU from DNA. In this report, we show that hNTH1 has 5-foU DNA glycosylase activity. Puri®ed recombinant hNTH1 formed a Schiff base intermediate with a 5-foU-containing oligonucleotide and cleaved it by b-elimination. In addition, hNTH1 excised oligonucleotides containing all 5-foU/N pairs (N = G, A, T or C), indicating that the enzyme recognizes the lesion 5-foU. This is the ®rst identi®cation of a human protein that has 5-foU DNA glycosylase activity.
MATERIALS AND METHODS

Enzymes and chemicals
Phenylmethylsulfonyl¯uoride, osmium tetroxide and NaBH 4 were purchased from Wako Pure Chemicals (Osaka, Japan). Ampicillin was obtained from Meiji Seika (Tokyo, Japan). T4 polynucleotide kinase was obtained from New England Biolabs (Beverly, MA). Glutathione±Sepharose 4B, thrombin, Sephadex G-25 and a prepacked Mono S column for FPLC were purchased from Amersham Pharmacia Biotech (Uppsala, Sweden). [g-32 P]ATP (>148 TBq/mmol) was obtained from ICN Biomedicals (Costa Mesa, CA).
Oligonucleotide substrates
A 5-foU-containing 17mer oligonucleotide with the sequence 5¢-GGTCGACTFAAGGTACC-3¢ (where F represents 5-foU) was synthesized as previously described (32) . In brief, an oligonucleotide containing 5-(1,2-dihydroxyethyl)uracil, the precursor of 5-foU, was synthesized by phosphoramidite chemistry using an ABI 381A DNA synthesizer (Perkin Elmer). Saturated NaIO 4 was added to a solution of the oligonucleotide containing the precursor and the reaction mixture was vortex mixed for 1 min at room temperature to convert 5-(1,2-dihydroxyethyl)uracil to 5-foU (32) . The presence of 5-foU in oligonucleotides was veri®ed by HPLC and HPLC/MS analyses. A Tg-containing 17mer oligonucleotide with the sequence 5¢-GGACGACAt¢AAGGAACC-3¢ (where t¢ represents Tg) was prepared according to Dianov et al. (33) . In brief, an oligonucleotide which contained a single thymine residue (5¢-GGACGACATAAGGAACC-3¢) was oxidized with 50 mM osmium tetroxide in the presence of 2% pyridine at room temperature. Then the oligonucleotide was puri®ed by gel ®ltration on Sephadex G-25. Other oligonucleotides were purchased from Espec (Nagoya, Japan) and Takara Shuzo (Kyoto, Japan).
Expression and puri®cation of the recombinant hNTH1 and E.coli Nth
The plasmid containing human hNTH1 cDNA was digested with BamHI and EcoRI, after which it was subcloned into BamHI + EcoRI-digested plasmid vector pGEX-4T-3. The resultant plasmid was named pGEX-4T-3-hNTH1. GST±hNTH1 fusion protein was expressed in E.coli KSR7 (nth nei mutM) (21) carrying pGEX4T-3-hNTH1 and the recombinant hNTH1 was puri®ed according to Matsumoto et al. (34) . Escherichia coli Nth was puri®ed according to Zhang et al. (21) .
DNA glycosylase/AP lyase assay for 5-foU-containing DNA
The DNA glycosylase/AP lyase assay was carried out at 37°C in a reaction mixture (10 ml) containing 20 fmol 32 P-labeled oligonucleotide and puri®ed Nth or hNTH1 in 20 mM Tris±HCl pH 8.0, 1 mM EDTA and 75 mM NaCl. The reaction was terminated by the addition of stop solution (95% formamide, 0.1% xylene cyanol and 20 mM EDTA). After heating at 95°C for 5 min, the samples were cooled on ice and then loaded onto 20% polyacrylamide gels in 90 mM Tris±borate pH 8.3, containing 7 M urea and 2 mM EDTA. After electrophoresis at 1300 V, the gels were dried and autoradiographed using Fuji RX ®lm at ±80°C. The intensity of each band was determined by image analysis using NIH Image software.
Trapping assay of protein±substrate intermediates with NaBH 4
The DNA trapping assay was performed at 37°C for 5 min in a reaction mixture (10 ml) containing 50 fmol 32 P-labeled oligonucleotide and puri®ed Nth or hNTH1 in 20 mM Tris±HCl pH 8.0, 1 mM EDTA and 50 mM NaBH 4 . The aqueous solution of NaBH 4 (0.5 M) was prepared just before use. The reaction was terminated by heating at 95°C for 5 min after the addition of an equal volume of standard loading buffer for SDS±PAGE. Trapped complexes were analyzed by 12% SDS±PAGE.
RESULTS
Cleavage of 5-foU-containing oligonucleotide by puri®ed hNTH1
To examine whether hNTH1 has 5-foU DNA glycosylase activity, we ®rst puri®ed the recombinant GST±hNTH1 fusion protein from GST±hNTH1-overexpressing E.coli cells (Fig. 1) . The GST±hNTH1 fusion protein (band A) was subsequently cleaved by thrombin to isolate the wild-type hNTH1. We observed two polypeptides of~36 and 34 kDa in addition to GST in the thrombin digest, indicating that thrombin cleaved at two sites in the fusion protein. Ikeda et al. (29) showed that the 34 kDa protein is a truncated form of hNTH1 lacking 22 residues at the N-terminus. We isolated the full-length (band B) and truncated (band C) proteins by chromatography on a Mono S column (Fig. 1) . The full-length and truncated hNTH1 proteins were eluted with 390 and 470 mM NaCl, respectively. Since the truncated hNTH1 protein showed much higher 5-foU-containing oligonucleotide cleaving activity, we used the truncated form of hNTH1 for further experiments.
We performed the DNA glycosylase/AP lyase assay as follows. 32 P-labeled oligonucleotide containing 5-foU or T was annealed to the complementary strand to construct 5-foU/ A or T/A base pair-containing duplex oligonucleotides, respectively. Each duplex oligonucleotide was incubated with the recombinant hNTH1 and then the reaction mixtures were electrophoresed on denaturing polyacrylamide gels. As shown in Figure 2A , the oligonucleotide was cleaved at the site of the 5-foU by the AP lyase activity of hNTH1 and E.coli Nth. The oligonucleotide containing a T/A base pair was not cleaved by these proteins. Prolonged incubation for 1 h with 24 ng hNTH1 did not cleave the T/A-containing oligonucleotides (data not shown). Sometimes the b-elimination products generated by AP lyases, e.g. endonuclease III, give rise to several separate bands in PAGE analysis, presumably because of Tris adduct formation and/or isomerization of the 3¢-hydroxypentenal terminus (21, 29) . These results indicate that hNTH1 has DNA glycosylase activity speci®c for 5-foU. The mobility of the cleavage product revealed that the enzyme cleaves the 5-foU-containing oligonucleotide by a b-elimination reaction.
It is known that hNTH1 forms a Schiff base intermediate with substrate DNA and subsequently cleaves the phosphodiester backbone of DNA via a b-elimination reaction (3,6±8). To determine whether hNTH1 forms a Schiff base intermediate with a 5-foU-containing oligonucleotide, we next performed a DNA trapping assay with NaBH 4 (35±38). As shown in Figure 2B , hNTH1 was trapped by a 5-foU-containing oligonucleotide, as was E.coli Nth. These results indicate that hNTH1 recognizes and cleaves 5-foU-containing oligonucleotides as natural substrates.
Ef®ciency of the 5-foU DNA glycosylase/AP lyase activity of hNTH1
Next, we compared the activity of hNTH1 for 5-foU with that for Tg. As an indicator of the enzymatic activity, we measured the initial velocity of the formation of the cleavage product (Fig. 3) . Then the intensity of the upper band was determined and the relative amount of product (nM/ng protein) is plotted in Figure 3B . Under the present conditions, hNTH1 maintained linear kinetics for~4 min with both substrates. The speci®c activities of cleavage of DNA containing 5-foU and Tg were 0.011 and 0.045 nM/min/ng protein, respectively. The DNA glycosylase activity of hNTH1 for 5-foU was about one-quarter of that for Tg. These results suggest that 5-foU is a good substrate for hNTH1 under physiological conditions.
Effects of the base opposite 5-FoU on DNA cleavage by hNTH1
5-foU in DNA arises by the oxidation of thymine in situ. Therefore, we used a substrate duplex oligonucleotide containing 5-foU paired with A. On the other hand, 5-foU in template DNA can direct misincorporation of mismatched bases opposite the lesion during DNA synthesis in vitro (18, 19) and in vivo (14±17). In addition, 5-formyl-dUTP can also be incorporated during in vitro DNA synthesis (11, 12) and causes mutations in E.coli (12, 13) . These results suggest that 5-foU/N (N = G, A, T or C) pairs are formed during DNA replication in E.coli cells. Therefore, we examined whether hNTH1 can recognize 5-foU in all types of base pairs in the substrate DNA. As shown in Figure 4 , hNTH1 cleaved oligonucleotides containing 5-foU/G, 5-foU/A, 5-foU/T and 5-foU/C, whereas none of the substrates containing T/G, A, T and C pairs were cleaved. These results indicate that hNTH1 does not recognize the 5-foU/N mismatches but the lesion itself in DNA. Next, we quanti®ed the intensity of each band and calculated the initial velocity of the cleavage reaction 
Formation of the Schiff base intermediate by hNTH1 with 5-foU-containing oligonucleotide
In Figure 2B we showed that hNTH1 forms a Schiff base intermediate with duplex oligonucleotides containing a 5-foU/ A pair. Next, we examined whether hNTH1 can form Schiff base intermediates with 5-foU/N and Tg/A (Fig. 5) . Bands A and C correspond to the trapped intermediates and free oligonucleotide, respectively. As shown in Figure 5 
DISCUSSION
5-foU is a major oxidative damage product derived from thymine. It has been shown that 5-foU in DNA is mutagenic to E.coli (12, 13, 15, 21) . To prevent mutations induced by 5-foU in DNA, proteins AlkA, MutM, Nth and Nei recognize and remove the lesion from DNA in E.coli (21, 22) . Mammalian cells also possess DNA glycosylase activities that remove 5-foU from DNA (23, 24) . In this study, we have shown that hNTH1, a human endonuclease III homolog, recognizes and cleaves duplex oligonucleotides containing a 5-foU ( Fig. 2A) . The speci®c activities of cleavage of DNA containing 5-foU and Tg were 0.011 and 0.045 nM/min/ng protein, respectively. Thus, hNTH1 shows 4-fold higher ef®ciency for Tg than 5-foU in DNA (Fig. 3) . Dizdaroglu et al. (39) reported that k cat values for the removal of damaged bases from oxidized DNA by hNTH1 vary by an order of magnitude. In addition, with de®ned oligonucleotide substrates E.coli Nth recognizes Tg with about 5-, 7-, 10-and 50-fold higher ef®ciency than uracil glycol, 5-hydroxycytosine, dihydrothymine and 5-hydroxyuracil, respectively (39) . From these results we conclude that 5-foU is a major substrate of hNTH1.
DNA glycosylases are divided into two groups: monofunctional and bifunctional DNA glycosylases. Monofunctional DNA glycosylases have only DNA glycosylase activity, whereas bifunctional DNA glycosylases possess both DNA glycosylase and AP lyase activity, by which they cleave the phosphodiester backbone in DNA (3,5±8). In the case of bifunctional DNA glycosylases, a nucleophilic amino group derived from the protein displaces the base, forming a protonated Schiff base intermediate, and subsequently the DNA strand is cleaved as a result of b-elimination (3,6±8). Some of these enzymes catalyze a subsequent d-elimination reaction (3,6±8). Escherichia coli Nth and human hNTH1 are bifunctional DNA glycosylases which catalyze b-elimination reactions (29, 40) . In this study, we have shown that hNTH1 cleaves the DNA strand via a b-elimination reaction, as does E.coli endonuclease III ( Fig. 2A) , and forms a Schiff base intermediate with the substrate oligonucleotides (Figs 2B and 5). These reactions were catalyzed by hNTH1 for all substrates containing 5-foU/N. Since T/N mismatched base pairs were not recognized by hNTH1, we conclude that hNTH1 does not recognize mismatched base pairs but rather the lesion 5-foU as an oxidized pyrimidine in DNA.
Both the 5-foU residue in template DNA and 5-formyldUTP added to the culture medium cause mutations in vivo and in vitro (11±19,21). Thus, it is likely that 5-foU in DNA is paired with bases other than A in E.coli cells. The present experimental results indicate that hNTH1 can remove 5-foU from DNA containing 5-foU/N mismatched base pairs (Fig. 4) . The initial velocities (V 0 ) for hNTH1 indicate the following preferences: Tg/A (relative V 0 = 1) > 5-foU/G (0.46) > 5-foU/ T (0.41) = 5-foU/C (0.41) > 5-foU/A (0.25). Therefore, we conclude that hNTH1 removes 5-foU mispaired with G, A, T and C, in that order of preference, from DNA.
Human hNTH1 is a structural and functional homolog of E.coli Nth (3,29±31). Mammalian cells have been shown to possess at least two kinds of DNA glycosylase activity that remove 5-foU from DNA (23, 24) . In this study, we have demonstrated that hNTH1 has 5-foU DNA glycosylase activity. Four kinds of DNA glycosylase can act on 5-foU in DNA in E.coli (20, 21) . Therefore, it is possible that mammalian cells also possess another 5-foU DNA glycosylase(s) in addition to hNTH1. Recently, Hazra et al. (28) reported the presence of two human orthologs of the E.coli nei gene in the human genome database and characterized one of their products. Based on the substrate preference, they named it NEH1 (Nei homolog). The wild-type recombinant NEH1, puri®ed to homogeneity from E.coli, excises formamidopyrimidines from damaged DNA and 8-oxoguanine and oxidized pyrimidines, such as thymine glycol, from oligonucleotides (28) . We also separately isolated a human homolog of E.coli Nei, named hNEI1. We found that hNEI1 recognized and ef®ciently cleaved oligonucleotides containing 5-foU (our unpublished results). However, further investigations will be needed to elucidate the molecular basis of the repair mechanisms for 5-foU in mammalian cells. 
